Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Republicans Pull Healthcare Legislation

Dustin Volz & David Lawder  |  March 27, 2017

WASHINGTON (Reuters)—President Donald Trump suffered a stunning political setback on Friday in a Congress controlled by his own party when Republican leaders pulled legislation to overhaul the U.S. healthcare system, a major 2016 election campaign promise of the president and his allies. Republican leaders of the House of Representatives pulled the legislation due to a…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceLegislationObamacare

Uncertain Fate of Obamacare Causes Some Hospitals to Halt Projects, Hiring

Robin Respaut and Yasmeen Abutaleb  |  March 23, 2017

WASHINGTON (Reuters)—Uncertainty surrounding the Republican plan to replace Obamacare is forcing some U.S. hospitals to delay expansion plans, cut costs, or take on added risk to borrow money for capital investment projects, dealing an economic blow to these facilities and the towns they call home. Hospitals typically lay out multi-year operating plans that prioritize investments,…

Filed under:Legislation & AdvocacyPractice SupportProfessional Topics Tagged with:Affordable Care Act (ACA)Denver Health Medical Centerhealthcare lawKingman Regional Medical CenterMedicaidObamacareRepublican-proposed billUniversity of Alabama at Birmingham Health System

New Findings on Rheumatic Drug Therapies among Patients with Ankylosing Spondylitis, Gout, SLE

Thomas R. Collins  |  March 20, 2017

WASHINGTON, D.C.—Taking high-dose non-steroidal anti-inflammatory drugs (NSAIDs) with a TNF inhibitor as an ankylosing spondylitis (AS) patient is linked with a 61% decrease in the chances your disease will progress, suggesting there may be a synergy when the drugs are used together, according to a longitudinal observational study from researchers at the University of California,…

Filed under:Axial SpondyloarthritisConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:2016 ACR/ARHP Annual MeetingAllopurinolAmerican College of Rheumatology (ACR)Ankylosing SpondylitisGoutnonsteroidal anti-inflammatory drugsNSAIDoutcomepatient careRheumatic DiseaserheumatologistrheumatologySLESystemic lupus erythematosus

Outdoor Lifestyle Is Lifelong Pursuit for Rheumatologist Dr. Mary Moran

Carol Patton  |  March 20, 2017

Mary Moran (now an MD) had just turned 20 years old and wondered if she’d make it through that day in May. She was sailing on a 30-foot open boat—no cabin below—for 26 days off the coast of Maine with 10 strangers who knew very little about sailing. On the third day, storm clouds rolled…

Filed under:AudioRheum After 5 Tagged with:Dr. Mary MoranhobbylifestyleOutward Boundrheumatologist

CHARAN RATTANASUPPHASIRI/shutterstock.com

Funding Sources for Scientific Discovery, Medical Research

Simon M. Helfgott, MD  |  March 20, 2017

The Phone Call A phone call in the middle of the night can rattle one’s nerves. The rush of adrenaline sets the heart pounding as our ears brace for what we are about to hear next. A distress call from an elderly parent or a child away at college? Is everyone safe? Or may this…

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:discoveryfinancialFundinginvestmentmedicalNational Institutes of HealthPhilanthropyResearchrheumatologysupport

Oksana Kuzmina/shutterstock.comx

Environmental Factors in Pediatric Systemic Autoimmune Diseases

Lisa G. Rider, MD, & Frederick W. Miller, MD, PhD  |  March 20, 2017

Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

Filed under:Conditions Tagged with:air pollutionAutoimmune diseaseenvironmental factorgeneticInfectionJuvenile idiopathic arthritisKawasaki diseasepatient carePediatricsRheumatic DiseaserheumatologistriskSmoking

How to Diagnose Antisynthetase Syndrome

How to Diagnose Antisynthetase Syndrome

Quretul Quresh, MD, & Stephen Lindsey, MD  |  March 17, 2017

Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD). Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these…

Filed under:ConditionsMyositisOther Rheumatic ConditionsResearch Rheum Tagged with:aminoacyl-transfer RNAAntisynthetase SyndromeClinicalDiagnosisinflammatoryInterstitial Lung DiseaseMyopathiesmyositisoutcomepatient careResearchrheumatologistrheumatologysyndromeTreatment

The ACR’s Representation in American Medical Association Critical as Review Looms

Sharad Lakhanpal, MBBS, MD  |  March 17, 2017

There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

Filed under:President's Perspective Tagged with:AC&RAdvocacyAMAAmerican Board of Internal Medicine (ABIM)American College of Rheumatology (ACR)American Medical Association (AMA)benefitsmembershipreviewrheumatologist

What Our Colleagues Should Know: Neurologists & Rheumatologists Must Communicate

Richard Quinn  |  March 17, 2017

Neurologists and rheumatologists focus on atypical diseases, and their treatments often require insights from both specialties. Philip Seo, MD, MHS, says communication between specialists is key to diagnosis and treatment…

Filed under:Professional Topics Tagged with:central nervous systemNeurologyrheumatologist

AHCA, ACR Health Policy & More

Angus B. Worthing  |  March 16, 2017

Editor’s note: This blog by Dr. Worthing originally appeared on the ACR’s Advocacy Listserv. What a month! House Republicans introduced their bill to repeal and replace Obamacare. The ACR has analyzed the bill and believes the American Health Care Act (AHCA) does not go far enough to help Americans with rheumatic diseases. Brief recap: The…

Filed under:From the CollegeLegislation & Advocacy Tagged with:ACR Government Affairs CommitteeAmerican Health Care Act (AHCA)health policyimmigration orderObamacareTrump administration

  • « Previous Page
  • 1
  • …
  • 200
  • 201
  • 202
  • 203
  • 204
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences